| # | Drug | Count |
|---|---|---|
| 0 | BISOPROLOL FUMARATE | 2 |
| 1 | IBRUTINIB | 2 |
| 2 | BENDAMUSTINE HCL | 1 |
| 3 | BLINATUMOMAB | 1 |
| 4 | CAPECITABINE | 1 |
| 5 | CARBOPLATIN | 1 |
| 6 | CYCLOPHOSPHAMIDE | 1 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 1 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 1 |
| 9 | DOXORUBICIN | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | REVUMENIB | 1 | 0.0010 |
| 1 | POLATUZUMAB VEDOTIN | 1 | 0.0001 |
| 2 | BLINATUMOMAB | 1 | 0.0001 |
| 3 | PEGFILGRASTIM | 1 | 0.0001 |
| 4 | BENDAMUSTINE HCL | 1 | 0.0001 |
| 5 | IBRUTINIB | 2 | 0.0000 |
| 6 | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | 0.0000 |
| 7 | BISOPROLOL FUMARATE | 2 | 0.0000 |
| 8 | DOXORUBICIN | 1 | 0.0000 |
| 9 | CAPECITABINE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-23 Antagonist [EPC] | 1 | 0.0000 |
| 1 | Serotonin-3 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 2 | Leukocyte Growth Factor [EPC] | 1 | 0.0000 |
| 3 | Alkylating Drug [EPC] | 1 | 0.0000 |
| 4 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Kinase Inhibitor [EPC] | 2 | 0.0000 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 1 | 0.0000 |
| 9 | Corticosteroid [EPC] | 1 | 0.0000 |